Tag Archives: HemoSonics

November 2023—HemoSonics announced that its Quantra hemostasis system received an Innovative Technology contract award from Vizient. The Quantra system consists of the Quantra hemostasis analyzer with QPlus and QStat cartridges and provides comprehensive whole-blood coagulation analysis at the point of care in less than 15 minutes.  

Aug. 4, 2023—HemoSonics announced that its Quantra hemostasis system has received an Innovative Technology contract award from Vizient, whose members include more than half of all acute care hospitals in the United States.

January 2023—HemoSonics has received FDA 510(k) clearance for the Quantra hemostasis system with QStat cartridge. The clearance of the QStat cartridge expands the Quantra system’s indications for use to include trauma and liver transplant procedures.

Dec. 1, 2022—HemoSonics received FDA 510(k) clearance for the Quantra hemostasis system with QStat cartridge.

July 2019—HemoSonics announced that its Quantra Hemostasis Analyzer platform and QPlus cartridge have been granted de novo marketing authorization by the FDA and are available for sale in the United States.

May 3, 2019–HemoSonics announced that its Quantra Hemostasis Analyzer platform and QPlus cartridge have been granted de novo marketing authorization by the FDA and are available for sale in the United States.